CADPS anticorps (N-Term)

N° du produit ABIN6990891

Détail du produit anti-CADPS anticorps

Antigène: CADPS (Ca++-Dependent Secretion Activator (CADPS))

Épitope: AA 90-140, N-Term

Reactivité: Humain, Souris, Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp CADPS est non-conjugé

Application: Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunofluorescence (IF)

Specificité: Numerous isoforms of CAPS1 are known to exist. This CAPS1 antibody is predicted to be specific to CAPS1 and not recognize CAPS2.

Purification: CAPS1 Antibody is affinity chromatography purified via peptide column.

Immunogène: CAPS1 antibody was raised against a 21 amino acid synthetic peptide near the amino terminus of the human CAPS1. The immunogen is located within amino acids 90 - 140 of CAPS1.

Isotype: IgG

Information d'application

Indications d'application: CAPS1 antibody can be used for detection of CAPS1 by Western blot at 0.25 - 0.5 μ,g/mL. Antibody can also be used for immunohistochemistry starting at 5 μ,g/mL. For immunofluorescence start at 20 μ,g/mL.

Antibody validated: Western Blot in rat samples, Immunohistochemistry in human samples and Immunofluorescence in human samples. All other applications and species not yet tested.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: CAPS1 Antibody is supplied in PBS containing 0.02 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,4 °C

Stockage commentaire: CAPS1 antibody can be stored at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

Détails sur CADPS

Antigène: CADPS (Ca++-Dependent Secretion Activator (CADPS))

Autre désignation: CAPS1 (CADPS Produits)

Synonymes: anticorps CADPS1, anticorps CAPS, anticorps CAPS1, anticorps Caps, anticorps Caps1, anticorps Caps2, anticorps AU067781, anticorps mKIAA1121, anticorps CADPS, anticorps cadps, anticorps MGC122552, anticorps CAPS-1, anticorps caps, anticorps caps1, anticorps si:busm1-1i3.1, anticorps si:busm1-6a2.7, anticorps si:dz6a2.7, anticorps calcium dependent secretion activator, anticorps Ca2+-dependent secretion activator, anticorps Ca2+-dependent activator protein for secretion b, anticorps Ca2+ dependent secretion activator, anticorps Ca2+ dependent secretion activator L homeolog, anticorps Ca2+-dependent activator protein for secretion a, anticorps CADPS, anticorps Cadps, anticorps cadpsb, anticorps cadps, anticorps cadps.L, anticorps cadpsa

Sujet: CAPS1 Antibody: CAPS1 and its related protein CAPS2 encode novel neural/endocrine-specific cytosolic and peripheral membrane proteins. Both are essential components of the synaptic vesicle priming machinery and are required for the Ca2+-regulated exocytosis of secretory vesicles, CAPS-deficienct neurons contain no or very few fusion competent synaptic vesicles, causing a selective impairment of fast phasic transmitter release. CAPS1 acts at a stage in exocytosis that follows ATP-dependent priming, which involves the essential synthesis of phosphatidylinositol 4, 5-bisphosphate and is thought to be a specific regulator of large dense-core vesicle fusion.

ID gène: 8618

NCBI Accession: NP_899631

UniProt: Q9ULU8

Pathways: Synaptic Vesicle Exocytosis